- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01915095
Improving Motor Function After Spinal Cord Injury
Enhancement of Hand Motor Function After Cervical Spinal Cord Injury
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33125
- Miami VA Healthcare System, Miami, FL
-
-
Illinois
-
Hines, Illinois, United States, 60141-5000
- Edward Hines Jr. VA Hospital, Hines, IL
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15240
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Male and female Veterans and non Veterans with spinal cord injury at least 6 months after injury was sustained. The investigators also plan to enroll control subjects who do not have any history of spinal cord injury.
Participants who are unimpaired healthy controls:
- Male and females between ages 18-85 years
- Right handed
- Able to complete precision grips with both hands
- Able to complete full wrist flexion-extension bilaterally
- Able to walk unassisted
- Able to complete full ankle flexion-extension bilaterally
Participants who have had a spinal cord injury:
- Male and females between ages 18-85 years
- Chronic SCI ( 6 months of injury)
- Spinal Cord injury at or above L5
- The ability to produce a visible precision grip force with one hand
- Individuals who have the ability to pick up a small object (large paperclip) from a table independently
- Able to perform some small wrist flexion and extension (measured by a goniometer)
- The ability to perform a small visible contraction with dorsiflexor and hip flexor muscles
- No subjects will be excluded based on their race, religion, ethnicity, gender or HIV status.
Exclusion Criteria:
Exclusion criteria for enrollment For SCI and Healthy Control Subjects (for stimulation):
- Uncontrolled medical problems including pulmonary, cardiovascular or orthopedic disease
- Any debilitating disease prior to the SCI that caused exercise intolerance
- Premorbid, ongoing major depression or psychosis, altered cognitive status
- History of head injury or stroke
- Metal plate in skull
- History of seizures
- Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold (see appendix 2)
- Pregnant females
- Ongoing cord compression or a syrinx in the spinal cord or who suffer from a spinal cord disease such as spinal stenosis, spina bifida, MS, or herniated cervical disk
- Individuals with scalp shrapnel, cochlear implants, or aneurysm clips.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Motor task+ Magnetic stimulation
Participants will be asked to complete a precision grip with the index and thumb finger at the same time as flexing or extending the wrist.
magnetic stimulation to the brain will be administered and measurements will be taken during movement.
|
small magnetic pulses will be given to the brain in a non invasive manner.
sham or fake stimulation (TMS or rTMS) will be given to the brain in a non invasive manner
participants will be asked to perform specific motor tasks or movements with their fingers, hands, arms or legs.
|
|
Active Comparator: rTMS/sham rTMS
Participant will be randomly assigned to one of 3 groups: repetitive transcranial magnetic stimulation (rTMS), sham (fake) rTMS, or sham (fake) rTMS over control brain area will be administered to the brain.
the stimulation will be targeting finger and wrist muscles during movement.
|
small magnetic pulses will be given to the brain in a non invasive manner.
sham or fake stimulation (TMS or rTMS) will be given to the brain in a non invasive manner
|
|
Active Comparator: Training + rTMS/ Sham rTMS
Participants will be asked to follow a target line on the computer as accurately as possible while performing precision grips or foot movement .
Magnetic stimulation will be given during rest and movement.
|
small magnetic pulses will be given to the brain in a non invasive manner.
sham or fake stimulation (TMS or rTMS) will be given to the brain in a non invasive manner
at the direction of the researcher the participant will be instructed to do repetitive motor movements with their arm, hand or leg.
this is called training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physiology Measurements Before and After rTMS/Sham rTMS Protocol- Changes in Amplitude of Motor Evoked Potential (MEP) From TMS
Time Frame: Post rTMS, Sham rTMS, and Sham rTMS over control brain for all sessions at minute 0, 10, 30, and 60
|
For Wrist flexion and precision grip + rTMS/Sham rTMS and Wrist extension and precision grip + rTMS/Sham rTMS we measured the changes in the MEPs before the intervention(rTMS/Sham rTMS) at minute 0, 10, 30, and 60 and then again after at minute 0, 10, 30, and 60. The information below is separated first by wrist flexion or extension, then by study visit (rTMS or Sham rTMS), and finally by subject characteristic (SCI or control). This study is a crossover design, what that means is subjects (SCI and Controls) will participate in both sessions (rTMS and Sham rTMS). For rTMS/Sham rTMS/Sham rTMS over control brain area we measured the changes in the MEPs at minute 0, 10, 30, and 60.The information for this arm is separated by study visit: Session 1 is rTMS, Session 2 is Sham rTMS, and Session 3 is Sham rTMS over control brain area. For Training + rTMS and Training + Sham rTMS we measured the changes in the MEPs at baseline, post 5 training sessions, and post all training sessions. |
Post rTMS, Sham rTMS, and Sham rTMS over control brain for all sessions at minute 0, 10, 30, and 60
|
|
Electromyography (EMG)
Time Frame: Before and After the stimulation during each 2-hour session (rTMS/Sham rTMS/Sham rTMS over control brain area)
|
For rTMS/Sham rTMS/Sham rTMS over control brain area we measured voluntary output in hand muscles using EMG before and after the stimulation.The information for this arm is separated by study visit: Session 1 is rTMS, Session 2 is Sham rTMS, and Session 3 is Sham rTMS over control brain area.
|
Before and After the stimulation during each 2-hour session (rTMS/Sham rTMS/Sham rTMS over control brain area)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Jebsen Taylor Hand Function Test (JTT)
Time Frame: The JTT was measured at Baseline, Post 5 training sessions, and Post all training sessions at each 2-hour session.
|
The JTT is a standardized test of several major aspects of hand function using simulated activities of daily living (writing, picking up small objects, picking up heavy objects etc.).
The time taken to perform simulated activities of daily living is assessed.
Lesser time to perform the activities would be considered a better outcome.
|
The JTT was measured at Baseline, Post 5 training sessions, and Post all training sessions at each 2-hour session.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Monica A Perez, PhD, Edward Hines Jr. VA Hospital, Hines, IL
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B0815-R
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.